ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups TrendingStockAlerts · Apr 28, 2025
Symphony Robotics Welcomes Neurosurgery Leader Dr. Neil A. Martin as Chief Medical Officer to Revolutionize Glioblastoma Treatment with First-Ever MRI-Steerable Micro-Robotics TrendingStockAlerts · Apr 27, 2025
Announcement of Paper Publication: EditForce Demonstrates Efficacy of Treatment for Myotonic Dystrophy Type 1 Using PPR Platform Technology TrendingStockAlerts · Apr 26, 2025
Novo Holdings and EIFO invest €48 million in HealthCap IX to strengthen the Nordic life sciences ecosystem TrendingStockAlerts · Apr 25, 2025
Kanazawa University Research: Visualizing the Mechanics of Hormone-Driven Gene Activation: Insights into Breast Cancer TrendingStockAlerts · Apr 24, 2025
Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab TrendingStockAlerts · Apr 23, 2025
DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies TrendingStockAlerts · Apr 22, 2025
YB-800 ADCs Reach Important Milestone: Proof of Concept in Preclinical in Vitro and in Vivo Tests TrendingStockAlerts · Apr 21, 2025
Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis TrendingStockAlerts · Apr 20, 2025
VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model TrendingStockAlerts · Apr 19, 2025
Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights TrendingStockAlerts · Apr 18, 2025
GMO/Toxin Free USA Sues Perfect Day Alleging Misleading Claims About "Animal Free Dairy" TrendingStockAlerts · Apr 17, 2025
